Request for proposals - supply of abiraterone and novel androgen receptor inhibitors in New Zealand

Pharmac invites proposals for the supply of abiraterone and novel androgen receptor inhibitors (nARIs) in New Zealand.

This Request for Proposals (RFP) letter incorporates the following schedules:

• Schedule 1: specifies the pharmaceuticals for which Pharmac is requesting proposals and sets out the background to the RFP and the types of proposals sought;
• Schedule 2: describes the process that Pharmac expects to follow in relation to the RFP;
• Schedule 3: sets out information about the estimated size of the current subsidised market for the pharmaceuticals;
• Attachment 1: is the form in which you can provide non-price information;
• Attachment 2: is the form in which you can provide price information;
• Attachment 3: contains Pharmac’s standard terms and conditions for supply of pharmaceuticals;
• Attachment 4: contains the standard Principal Supply Status terms; and
• Attachment 5: is the New Zealand Government Supplier Code of Conduct.